Bloom Public Health Botswana team visits MDB Pharma to establish a strategic partnership with MDB Pharma to support the growth, development, and regional expansion of Botswana’s pharmaceutical sector.
June 30, 2026
Bloom Public Health Lesotho and Lintle Envirotech Consultancy Partner to Strengthen Pharmaceutical Waste Management
June 30, 2026Government, industry, regulators, and development partners unite to strengthen pharmaceutical manufacturing and regulatory excellence.
Stakeholders from across Zambia’s pharmaceutical sector convened in Lusaka for the National Stakeholders Dialogue on Advancing Good Manufacturing Practice (GMP) and Related Regulatory Compliance, reaffirming a shared commitment to strengthening local pharmaceutical manufacturing and improving regulatory standards.
The dialogue brought together representatives from government institutions, regulatory authorities, pharmaceutical manufacturers, development partners, and other key stakeholders to examine practical strategies for building a competitive, resilient, and internationally compliant pharmaceutical manufacturing ecosystem in Zambia.
Discussions focused on the critical role of Good Manufacturing Practice (GMP) in ensuring the quality, safety, and efficacy of medicines while enhancing the competitiveness of locally manufactured pharmaceutical products. Participants also explored opportunities to strengthen regulatory compliance, improve manufacturing capacity, promote industry collaboration, and create an enabling environment for sustainable sector growth.
The forum provided a valuable platform for technical presentations, knowledge exchange, and cross-sector dialogue, reinforcing the importance of collaboration in addressing shared challenges and accelerating the development of Zambia’s pharmaceutical industry. Through meaningful engagement between policymakers, regulators, manufacturers, and development partners, the dialogue highlighted the collective responsibility required to advance manufacturing excellence and improve access to quality-assured medicines.
Bloom Public Health remains committed to supporting initiatives that strengthen pharmaceutical quality systems, build regulatory capacity, and promote local manufacturing across Africa. By fostering strategic dialogue and technical collaboration, the organization continues to contribute to the development of resilient pharmaceutical ecosystems that improve health security and expand access to safe, effective, and affordable medicines.
